Aspirin in Reducing Events in the Elderly



Status:Active, not recruiting
Conditions:Cancer, Cancer, Depression, Peripheral Vascular Disease, Cardiology, Neurology
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology, Oncology, Psychiatry / Psychology
Healthy:No
Age Range:65 - Any
Updated:12/21/2018
Start Date:January 2010
End Date:January 2019

Use our guide to learn which trials are right for you!

ASPREE-XT is a post-treatment, longitudinal observational follow-up study of ASPREE
participants [ASPREE Investigator Group, 2013; www.aspree.org; McNeil et al 2017]. Although
the ASPREE trial medication was ceased, the study activity was not stopped and ASPREE
participants are continuing with scheduled visits and phone calls. An observational follow-up
phase (ASPREE-XT), began in January, 2018. This will enable the monitoring of possible
delayed effects of aspirin treatment, primarily on cancer incidence, metastases and
mortality. In addition to monitoring the incidence of malignancy within the ASPREE cohort,
the opportunity will be taken to observe any other residual effects of aspirin on the
endpoints being monitored in the cohort. Continuity of contact with study participants is the
key to retention of the cohort for any ongoing or future studies.

ASPREE BACKGROUND:

ASPREE (ASPirin in Reducing Events in the Elderly) is a joint US/Australian research project
aiming to determine whether low-dose aspirin increases healthy life-span, defined as survival
free of dementia and disability. ASPREE began in 2010 and completed recruitment in 2014. It
is a randomized, double-blind, placebo-controlled, primary prevention trial of daily 100 mg
of aspirin in a population of healthy older people in the United States (US) and Australia
with a period of treatment averaging 4.5 years. ASPREE's primary outcome is length of
survival free of dementia and disability and has secondary outcomes encompassing the major
health issues related to aging. The trial involving 19,114 persons aged 70 and above (65
years and above for US minorities) is distinctive for its large size, methodological rigor
and high participant retention rate in both countries.

ASPREE UNIQUE ASPECTS:

1. It is the first large scale trial to incorporate dementia-free and disability-free
survival as a primary outcome. This is now recognized as an appropriate goal of
treatment in a primary prevention population of this age group. Within a clinical trial
context disability-free survival incorporates an estimate of the overall benefits and
risks of aspirin in a single outcome measure.

2. It is one of the first primary prevention trials of aspirin to include cancer incidence,
metastases or mortality as a pre-specified endpoint. Recent meta-analyses [Rothwell et
al 2010, 2011, 2012] suggests that aspirin has a significant chemopreventive effect
becoming evident after a period of 4+ years of aspirin treatment, but questions remain
about the magnitude of benefit, and whether it applies to treatment of all cancers and
to older people.

3. It will provide information about the impact of aspirin on a range of other conditions
(e.g, dementia, CVD, stroke, depression, bleeding) where aspirin has been claimed to
have benefit (or risks).

The intervention phase of the trial ended in June 2017 after the NIA determined that it was
highly unlikely that aspirin would show a benefit on the overall primary outcome within the
planned 5-year time frame. The study is now entering a data cleaning and analysis phase and
it is anticipated that the primary results were published in September 2018.

Inclusion Criteria:

- Men and women

- African American and Hispanic persons age 65 or older

- Any person from another ethnic minority group and Caucasian persons age 70 or older

- Willing and able to provide informed consent, and willing to accept the study
requirements

Exclusion Criteria:

- A history of a diagnosed cardiovascular event

- A serious intercurrent illness likely to cause death within the next 5 years, such as
terminal cancer or obstructive airways disease

- A current or recurrent condition with a high risk of major bleeding, ex: cerebral
aneurysm

- Anemia

- Absolute contraindication or allergy to aspirin

- Current participation in a clinical trial

- Current continuous use of aspirin or other anti-platelet drug or anticoagulant for
secondary prevention. People with previous use of aspirin for primary prevention may
enter the trial, provided they agree to cease existing use of aspirin and understand
that they may be subsequently randomly allocated to low dose aspirin or placebo.

- A systolic blood pressure ≥180 mmHg and / or a diastolic blood pressure ≥105 mmHg

- A history of dementia

- Severe difficulty or an inability to perform any one of the 6 Katz ADLs

- Non-compliance to taking pill
We found this trial at
33
sites
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
5323 Harry Hines Blvd
Dallas, Texas 75235
(214) 648-3111
Univ of Texas, Southwestern Med Ctr of Dallas The story of UT Southwestern Medical Center...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
5050 Anthony Wayne Dr
Detroit, Michigan 48201
(313) 577-2424
Wayne State University Founded in 1868, Wayne State University is a nationally recognized metropolitan research...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
University of Iowa With just over 30,000 students, the University of Iowa is one of...
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
Atlanta, Georgia 30322
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atlanta, Georgia
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1459 Laney-Walker Blvd
Augusta, Georgia 30901
(706) 721-3052
Georgia Health Sciences University Georgia Regents University, home of the Medical College of Georgia, is...
?
mi
from
Augusta, GA
Click here to add this to my saved trials
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
6400 Perkins Rd
Baton Rouge, Louisiana 70808
(225) 763-2500
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Elizabeth, New Jersey 07202
?
mi
from
Elizabeth, NJ
Click here to add this to my saved trials
2004 Mowry Road
Gainesville, Florida 32611
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Galveston, Texas 77555
?
mi
from
Galveston, TX
Click here to add this to my saved trials
Greensboro, North Carolina 27408
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
Greenville, North Carolina 27834
?
mi
from
Greenville, NC
Click here to add this to my saved trials
Harlingen, Texas 78550
?
mi
from
Harlingen, TX
Click here to add this to my saved trials
Kansas City, Kansas
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
?
mi
from
Memphis, TN
Click here to add this to my saved trials
259 1st St
Mineola, New York 11501
(516) 663-0333
Winthrop University Hospital Founded in 1896 by a group of local physicians and concerned citizens,...
?
mi
from
Mineola, NY
Click here to add this to my saved trials
Minneapolis, Minnesota 55425
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
New Orleans, Louisiana 70112
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New Orleans, Louisiana 70112
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Novi, Michigan 48337
?
mi
from
Novi, MI
Click here to add this to my saved trials
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
111 Brewster St
Pawtucket, Rhode Island 02860
(401) 729-2000
Memorial Hospital of Rhode Island Memorial Hospital of Rhode Island is a 294-bed community teaching...
?
mi
from
Pawtucket, RI
Click here to add this to my saved trials
5501 Old York Road
Philadelphia, Pennsylvania 19141
215-456-7890
Albert Einstein Medical Center Einstein Healthcare Network is a private, not-for-profit organization with several major...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1414 Maryland Avenue East
Saint Paul, Minnesota 55106
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
San Antonio, Texas 78229
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Shreveport, Louisiana 71130
?
mi
from
Shreveport, LA
Click here to add this to my saved trials
Washington, District of Columbia 20060
?
mi
from
Washington,
Click here to add this to my saved trials